AbbVie Inc. CDR (ABBV)
Market Open
3 Mar, 18:31
NEO-L NEO-L Primary 
XFRA CA$
32. 84
+0.07
+0.21%
CA$
- Market Cap
42.2 P/E Ratio
1.63% Div Yield
6,100 Volume
10.28 Eps
CA$ 32.77
Previous Close Day Range
32.42 33.01
Year Range
23.68 34.59
Want to track ABBV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ABBV earnings report is expected in 51 days (23 Apr 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ABBV Earnings Reports FAQ
What is the earnings per share (EPS) for ABBV?
The current EPS is 10.28.
What is the company's earnings growth rate?
AbbVie Inc. CDR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-04-23, based on the ABBV's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for AbbVie Inc. CDR are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ABBV at this time, as AbbVie Inc. CDR has no recent EPS data to calculate it.
